Trial intelligence / Profile preview

NRL994 vs Sodium Phosphate for Colonoscopy Preparation

NCT00322062Phase 3Completed

Sponsor
Norgine
Start
Apr 2002
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of macrogol in colonoscopy (2 arms), sponsored by Norgine. Primary endpoint: Overall quality of colonoscopy prep. Started Apr 2002; status: completed.

02

Drugs

macrogol
03

Conditions

colonoscopy

Beyond the preview

Go deeper on NCT00322062.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00322062.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call